Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
US Patent Number
9,586,992
Publication Date
3-7-2017
Abstract
The present invention relates to novel proteins, referred to herein as amidated glial cell line-derived neurotrophic factor (GDNF) peptides (or "Amidated Dopamine Neuron Stimulating peptides (ADNS peptides)"), that are useful for treating brain diseases and injuries that result in dopaminergic deficiencies.
Assignees
University of Kentucky Research Foundation, Lexington, KY (US)
Application Number
14/153,844
Filing Date
1-13-2014
Recommended Citation
Bradley, Luke H.; Gash, Don M.; and Gerhardt, Greg A., "Amidated Dopamine Neuron Stimulating Peptides for CNS Dopaminergic Upregulation" (2017). Neuroscience Faculty Patents. 10.
https://uknowledge.uky.edu/neurobio_patents/10
